Quarterly report · Q3

Period2022-04-01 → 2022-12-31
Filed2023-02-14
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 37
MetricValuePeriodScopeSource row
Revenue¥4.9bn2022-04-01 → 2022-12-31StandaloneNet sales
Revenue¥5.8bn2021-04-01 → 2022-03-31StandaloneNet sales (5-year summary)
Revenue¥4.3bn2021-04-01 → 2021-12-31StandaloneNet sales
Operating income¥398m2022-04-01 → 2022-12-31StandaloneOperating income
Operating income¥360m2021-04-01 → 2021-12-31StandaloneOperating income
Ordinary income¥406m2022-04-01 → 2022-12-31StandaloneOrdinary income
Ordinary income¥506m2021-04-01 → 2022-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥345m2021-04-01 → 2021-12-31StandaloneOrdinary income
Profit before tax¥384m2022-04-01 → 2022-12-31StandaloneIncome before income taxes
Profit before tax¥343m2021-04-01 → 2021-12-31StandaloneIncome before income taxes
Net income¥260m2022-04-01 → 2022-12-31StandaloneProfit loss
Net income¥328m2021-04-01 → 2022-03-31StandaloneNet income loss (5-year summary)
Net income¥231m2021-04-01 → 2021-12-31StandaloneProfit loss
Total assets¥3.0bnat 2022-12-31StandaloneAssets
Total assets¥2.5bnat 2022-03-31StandaloneAssets
Total assets¥2.6bnat 2021-12-31StandaloneTotal assets (5-year summary)
Total liabilities¥1.7bnat 2022-12-31StandaloneLiabilities
Total liabilities¥1.5bnat 2022-03-31StandaloneLiabilities
Net assets / equity¥1.4bnat 2022-12-31StandaloneNet assets
Net assets / equity¥1.1bnat 2022-03-31StandaloneNet assets
Net assets / equity¥961mat 2021-12-31StandaloneNet assets (5-year summary)
Cash and deposits¥668mat 2022-12-31StandaloneCash and deposits
Cash and deposits¥720mat 2022-03-31StandaloneCash and deposits
EPS (basic)¥73.412022-04-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥22.772022-10-01 → 2022-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥95.82021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥67.812021-04-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥25.182021-10-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥69.042022-04-01 → 2022-12-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥88.282021-04-01 → 2022-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥62.422021-04-01 → 2021-12-31StandaloneDiluted earnings per share (5-year summary)
Equity ratio45.2%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio42.4%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio37.3%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Shares issued3,571,700at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued3,499,100at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued3,462,200at 2021-12-31StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥5m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥5m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31−¥74m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥309m
jpcrp040300-q3r_E37198-000Care Planning Servicereportable segmentrevenue2022-04-01 → 2022-12-31¥99m
jpcrp040300-q3r_E37198-000Care Planning Servicereportable segmentrevenue external2022-04-01 → 2022-12-31¥99m
jpcrp040300-q3r_E37198-000Care Planning Servicereportable segmentsegment profit2022-04-01 → 2022-12-31¥15m
jpcrp040300-q3r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue2022-04-01 → 2022-12-31¥4.3bn
jpcrp040300-q3r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue external2022-04-01 → 2022-12-31¥4.3bn
jpcrp040300-q3r_E37198-000Home Visit Pharmacist Servicereportable segmentsegment profit2022-04-01 → 2022-12-31¥498m
jpcrp040300-q3r_E37198-000Hospital Discharge Support Servicereportable segmentrevenue2022-04-01 → 2022-12-31¥33m
jpcrp040300-q3r_E37198-000Hospital Discharge Support Servicereportable segmentrevenue external2022-04-01 → 2022-12-31¥33m
jpcrp040300-q3r_E37198-000Hospital Discharge Support Servicereportable segmentsegment profit2022-04-01 → 2022-12-31−¥15m
jpcrp040300-q3r_E37198-000Kirari Primereportable segmentrevenue2022-04-01 → 2022-12-31¥461m
jpcrp040300-q3r_E37198-000Kirari Primereportable segmentrevenue external2022-04-01 → 2022-12-31¥461m
jpcrp040300-q3r_E37198-000Kirari Primereportable segmentsegment profit2022-04-01 → 2022-12-31¥283m
—segment totalrevenue2022-04-01 → 2022-12-31¥4.9bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥4.9bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥781m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥4.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥4.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥707m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-12-31¥8m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-12-31¥8m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-12-31−¥14m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31−¥243m
jpcrp040300-q3r_E37198-000Care Planning Servicereportable segmentrevenue2021-04-01 → 2021-12-31¥92m
jpcrp040300-q3r_E37198-000Care Planning Servicereportable segmentrevenue external2021-04-01 → 2021-12-31¥92m
jpcrp040300-q3r_E37198-000Care Planning Servicereportable segmentsegment profit2021-04-01 → 2021-12-31−¥4m
jpcrp040300-q3r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue2021-04-01 → 2021-12-31¥3.8bn
jpcrp040300-q3r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue external2021-04-01 → 2021-12-31¥3.8bn
jpcrp040300-q3r_E37198-000Home Visit Pharmacist Servicereportable segmentsegment profit2021-04-01 → 2021-12-31¥419m
jpcrp040300-q3r_E37198-000Hospital Discharge Support Servicereportable segmentrevenue2021-04-01 → 2021-12-31¥57m
jpcrp040300-q3r_E37198-000Hospital Discharge Support Servicereportable segmentrevenue external2021-04-01 → 2021-12-31¥57m
jpcrp040300-q3r_E37198-000Hospital Discharge Support Servicereportable segmentsegment profit2021-04-01 → 2021-12-31¥21m
jpcrp040300-q3r_E37198-000Kirari Primereportable segmentrevenue2021-04-01 → 2021-12-31¥305m
jpcrp040300-q3r_E37198-000Kirari Primereportable segmentrevenue external2021-04-01 → 2021-12-31¥305m
jpcrp040300-q3r_E37198-000Kirari Primereportable segmentsegment profit2021-04-01 → 2021-12-31¥182m
—segment totalrevenue2021-04-01 → 2021-12-31¥4.3bn
—segment totalrevenue external2021-04-01 → 2021-12-31¥4.3bn
—segment totalsegment profit2021-04-01 → 2021-12-31¥617m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥4.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥4.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥603m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 311
ItemContextValueUnit
Notes when there is significant changes in amounts of equity (text)CurrentYTDDuration_NonConsolidatedMemberText · Plus
Notes segment information etc quarterly financial statements (text)CurrentYTDDurationText · Plus
Footnotes regarding segment information table (text)Prior1YTDDuration_NonConsolidatedMemberText · Plus
Information about impairment loss of non current assets or goodwill etc for each reportable segment (text)Prior1YTDDuration_NonConsolidatedMemberText · Plus
Footnotes regarding segment information table (text)CurrentYTDDuration_NonConsolidatedMemberText · Plus
Information about impairment loss of non current assets or goodwill etc for each reportable segment (text)CurrentYTDDuration_NonConsolidatedMemberText · Plus
Notes revenue recognition quarterly financial statements (text)CurrentYTDDurationText · Plus
Notes per share information quarterly financial statements (text)CurrentYTDDurationText · Plus
Notes significant events after reporting period quarterly financial statements (text)CurrentYTDDurationText · Plus
Other information financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2022-03-31pass rounding
balance sheet identitynon_consolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2021-12-31pass
statement vs summary · revenuenon_consolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass